Literature DB >> 19337852

Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?

Johannes Giesinger1, Georg Kemmler, Verena Mueller, August Zabernigg, Beate Mayrbaeurl, Josef Thaler, Dietmar Ofner, Christian Pegger, Gerhard Rumpold, Barbara Weber, Barbara Sperner-Unterweger, Bernhard Holzner.   

Abstract

PURPOSE: The purpose of this study was to investigate gender-associated differences in quality of life in colorectal cancer patients and compare such differences to the general population.
METHODS: Colorectal cancer patients attending three oncological centres in Austria were consecutively recruited and assessed with the EORTC QLQ-C30. For the purpose of comparison, a gender- and age-matched healthy control group was drawn from a representative sample of the Austrian general population.
RESULTS: About 206 patients (47.1% women; mean age 64.8 years) with colorectal cancer were included and compared with 206 persons from the general population. A two-way analysis of variance showed significant main effects (gender and colorectal cancer vs. healthy) for most EORTC QLQ-C30 scales, but a significant interaction effect was only found for diarrhea. This means that gender-associated differences specific for colorectal cancer patients were only found for diarrhea.
CONCLUSION: The vast majority of studies on gender-associated differences in quality of life compare male and female oncological patients and neglect the issue of the disease-specificity of such differences. Our study revealed that women and men suffering from colorectal cancer scored differently across many aspects of quality of life, but with the exception of diarrhea, these differences were also found in the general population, i.e. they indicated no gender-specific reaction to disease.

Entities:  

Mesh:

Year:  2009        PMID: 19337852     DOI: 10.1007/s11136-009-9468-0

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  33 in total

1.  Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life.

Authors:  K Mystakidou; E Tsilika; E Parpa; E Katsouda; A Galanos; L Vlahos
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with colorectal cancer.

Authors:  T R Wilson; D J Alexander
Journal:  Br J Surg       Date:  2008-11       Impact factor: 6.939

3.  Gender-associated differences in the quality of life after allogeneic BMT.

Authors:  H Heinonen; L Volin; A Uutela; M Zevon; C Barrick; T Ruutu
Journal:  Bone Marrow Transplant       Date:  2001-09       Impact factor: 5.483

4.  Gender differences in long-term survival of patients with colorectal cancer.

Authors:  M W Wichmann; C Müller; H M Hornung; U Lau-Werner; F W Schildberg
Journal:  Br J Surg       Date:  2001-08       Impact factor: 6.939

5.  Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3).

Authors:  M J Hjermstad; P M Fayers; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

6.  Gender differences in quality of life of patients with rectal cancer. A five-year prospective study.

Authors:  Christian E Schmidt; Beate Bestmann; Thomas Küchler; Walter E Longo; Volker Rohde; Bernd Kremer
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

7.  Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.

Authors:  Jeff A Sloan; Richard M Goldberg; Daniel J Sargent; Delfino Vargas-Chanes; Suresh Nair; Steven S Cha; Paul J Novotny; Michael A Poon; Michael J O'Connell; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

8.  Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study.

Authors:  Volker Arndt; Henrike Merx; Christa Stegmaier; Hartwig Ziegler; Hermann Brenner
Journal:  J Clin Oncol       Date:  2004-12-01       Impact factor: 44.544

9.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

10.  Predicting gender differences as latent variables: summed scores, and individual item responses: a methods case study.

Authors:  Ricardo Pietrobon; Marcus Taylor; Ulrich Guller; Laurence D Higgins; Danny O Jacobs; Timothy Carey
Journal:  Health Qual Life Outcomes       Date:  2004-10-25       Impact factor: 3.186

View more
  8 in total

1.  Chemotherapy line-associated differences in quality of life in patients with advanced cancer.

Authors:  B Mayrbäurl; L M Wintner; J M Giesinger; Th Himmelfreundpointner; S Burgstaller; B Holzner; J Thaler
Journal:  Support Care Cancer       Date:  2011-12-29       Impact factor: 3.603

2.  Nutritional and psychosocial status of colorectal cancer patients referred to an outpatient oncology clinic.

Authors:  Helena Maria Lizardo Daudt; Cheri Cosby; Darcy L Dennis; Nancy Payeur; Rubayed Nurullah
Journal:  Support Care Cancer       Date:  2011-07-07       Impact factor: 3.603

3.  Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity.

Authors:  Therese Juul; Morten Aagaard Petersen; Bernhard Holzner; Søren Laurberg; Peter Christensen; Mogens Grønvold
Journal:  Qual Life Res       Date:  2014-03-28       Impact factor: 4.147

4.  Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy.

Authors:  Christine Miaskowski; Bruce A Cooper; Michelle Melisko; Lee-May Chen; Judy Mastick; Claudia West; Steven M Paul; Laura B Dunn; Brian L Schmidt; Marilyn Hammer; Frances Cartwright; Fay Wright; Dale J Langford; Kathryn Lee; Bradley E Aouizerat
Journal:  Cancer       Date:  2014-05-02       Impact factor: 6.860

5.  Latent Class Analysis Reveals Distinct Subgroups of Patients Based on Symptom Occurrence and Demographic and Clinical Characteristics.

Authors:  Christine Miaskowski; Laura Dunn; Christine Ritchie; Steven M Paul; Bruce Cooper; Bradley E Aouizerat; Kimberly Alexander; Helen Skerman; Patsy Yates
Journal:  J Pain Symptom Manage       Date:  2015-01-31       Impact factor: 3.612

6.  Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme.

Authors:  Eva-Maria Gamper; Lisa M Wintner; Margarida Rodrigues; Sabine Buxbaum; Bernhard Nilica; Susanne Singer; Johannes M Giesinger; Bernhard Holzner; Irene Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-13       Impact factor: 9.236

7.  Quality of life of early stage colorectal cancer patients in Morocco.

Authors:  Hind Mrabti; Mounia Amziren; Ibrahim ElGhissassi; Youssef Bensouda; Narjiss Berrada; Halima Abahssain; Saber Boutayeb; Samira El Fakir; Chakib Nejjari; Abdellatif Benider; Nawfel Mellas; Omar El Mesbahi; Maria Bennani; Rachid Bekkali; Ahmed Zidouh; Hassan Errihani
Journal:  BMC Gastroenterol       Date:  2016-10-12       Impact factor: 3.067

8.  Relationships between Death Anxiety and Quality of Life in Iranian Patients with Cancer.

Authors:  Mohammad A Soleimani; Rebecca H Lehto; Reza Negarandeh; Nasim Bahrami; Hamid Sharif Nia
Journal:  Asia Pac J Oncol Nurs       Date:  2016 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.